First Horizon Advisors’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10K | Hold |
156
| – | – | ﹤0.01% | 1680 |
|
|
2025
Q1 | $9.91K | Hold |
156
| – | – | ﹤0.01% | 1599 |
|
|
2024
Q4 | $10.4K | Hold |
156
| – | – | ﹤0.01% | 1586 |
|
|
2024
Q3 | $10.9K | Hold |
156
| – | – | ﹤0.01% | 1576 |
|
|
2024
Q2 | $10.1K | Hold |
156
| – | – | ﹤0.01% | 1528 |
|
|
2024
Q1 | $10.1K | Hold |
156
| – | – | ﹤0.01% | 1573 |
|
|
2023
Q4 | $10.3K | Hold |
156
| – | – | ﹤0.01% | 1586 |
|
|
2023
Q3 | $8.9K | Hold |
156
| – | – | ﹤0.01% | 1557 |
|
|
2023
Q2 | $9.56K | Hold |
156
| – | – | ﹤0.01% | 1562 |
|
|
2023
Q1 | $9.79K | Hold |
156
| – | – | ﹤0.01% | 1568 |
|
|
2022
Q4 | $9.91K | Hold |
156
| – | – | ﹤0.01% | 1564 |
|
|
2022
Q3 | $9K | Hold |
156
| – | – | ﹤0.01% | 1560 |
|
|
2022
Q2 | $9K | Buy |
+156
| New | +$9K | ﹤0.01% | 1632 |
|
|
2022
Q1 | – | Sell |
-156
| Closed | -$11K | – | 2136 |
|
|
2021
Q4 | $11K | Hold |
156
| – | – | ﹤0.01% | 1489 |
|
|
2021
Q3 | $11K | Hold |
156
| – | – | ﹤0.01% | 1502 |
|
|
2021
Q2 | $12K | Hold |
156
| – | – | ﹤0.01% | 1293 |
|
|
2021
Q1 | $11K | Hold |
156
| – | – | ﹤0.01% | 1263 |
|
|
2020
Q4 | $10K | Buy |
+156
| New | +$10K | ﹤0.01% | 1075 |
|